Mouwasat Medical Services Co. reported a net profit of SAR 85.1 million for Q1 2017, a 24.2 percent rise year-on-year (YoY) on higher revenue and effective utilization of resources. The revenue increase was a result of growth from the Riyadh branch and expansion in sub specialty clinics operations, the healthcare services provider said.
Sequentially, Q1 net profit rose 12.5 percent, mainly due to a 1 percent increase in revenue, lower selling and marketing expenses, and a decline in general and administrative expenses.
Item | Q1 2016 | Q1 2017 | Change |
---|---|---|---|
Revenues | 303.59 | 362.97 | 19.6 % |
Gross Income | 143.50 | 173.37 | 20.8 % |
Operating Income | 75.66 | 93.17 | 23.1 % |
Net Income | 68.47 | 85.12 | 24.3 % |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.34 | 0.43 | 24.3 % |
Item | Q4 2016 | Q1 2017 | Change |
---|---|---|---|
Revenues | 359.19 | 362.97 | 1.1 % |
Gross Income | 168.91 | 173.37 | 2.6 % |
Operating Income | 84.39 | 93.17 | 10.4 % |
Net Income | 75.65 | 85.12 | 12.5 % |
Average Shares | 200.00 | 200.00 | - |
EPS (Riyals) | 0.38 | 0.43 | 12.5 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2008 | 113.83 | - | 52.37 | - | 27.91 | - |
Q2 2008 | 118.48 | - | 53.79 | - | 29.33 | - |
Q3 2008 | 104.92 | - | 47.23 | - | 23.73 | - |
Q4 2008 | 117.32 | - | 47.51 | - | 29.27 | - |
2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 110.24 | 14.6 % |
Q1 2009 | 124.60 | 9.5 % | 56.25 | 7.4 % | 30.77 | 10.2 % |
Q2 2009 | 140.62 | 18.7 % | 67.77 | 26.0 % | 41.29 | 40.8 % |
Q3 2009 | 115.21 | 9.8 % | 54.05 | 14.4 % | 29.09 | 22.6 % |
Q4 2009 | 137.16 | 16.9 % | 49.94 | 5.1 % | 20.05 | (31.5 %) |
2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 121.20 | 9.9 % |
Q1 2010 | 143.79 | 15.4 % | 68.04 | 21.0 % | 39.35 | 27.9 % |
Q2 2010 | 148.78 | 5.8 % | 71.36 | 5.3 % | 41.41 | 0.3 % |
Q3 2010 | 134.72 | 16.9 % | 63.30 | 17.1 % | 29.14 | 0.2 % |
Q4 2010 | 160.20 | 16.8 % | 74.36 | 48.9 % | 32.98 | 64.5 % |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 142.87 | 17.9 % |
Q1 2011 | 166.82 | 16.0 % | 84.05 | 23.5 % | 45.72 | 16.2 % |
Q2 2011 | 164.93 | 10.9 % | 76.76 | 7.6 % | 41.80 | 0.9 % |
Q3 2011 | 156.92 | 16.5 % | 74.10 | 17.1 % | 39.80 | 36.6 % |
Q4 2011 | 189.77 | 18.5 % | 89.09 | 19.8 % | 41.95 | 27.2 % |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 169.26 | 18.5 % |
Q1 2012 | 195.57 | 17.2 % | 94.32 | 12.2 % | 53.36 | 16.7 % |
Q2 2012 | 200.62 | 21.6 % | 93.28 | 21.5 % | 51.87 | 24.1 % |
Q3 2012 | 187.28 | 19.3 % | 84.01 | 13.4 % | 37.08 | (6.8 %) |
Q4 2012 | 213.04 | 12.3 % | 101.10 | 13.5 % | 43.73 | 4.3 % |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 186.04 | 9.9 % |
Q1 2013 | 219.23 | 12.1 % | 110.39 | 17.0 % | 58.25 | 9.2 % |
Q2 2013 | 228.74 | 14.0 % | 116.90 | 25.3 % | 59.96 | 15.6 % |
Q3 2013 | 211.63 | 13.0 % | 104.34 | 24.2 % | 48.82 | 31.7 % |
Q4 2013 | 242.64 | 13.9 % | 124.17 | 22.8 % | 55.21 | 26.3 % |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 222.25 | 19.5 % |
Q1 2014 | 243.54 | 11.1 % | 124.18 | 12.5 % | 62.97 | 8.1 % |
Q2 2014 | 244.25 | 6.8 % | 124.14 | 6.2 % | 63.22 | 5.4 % |
Q3 2014 | 230.47 | 8.9 % | 113.02 | 8.3 % | 54.13 | 10.9 % |
Q4 2014 | 247.18 | 1.9 % | 117.49 | (5.4 %) | 52.86 | (4.3 %) |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 233.17 | 4.9 % |
Q1 2015 | 253.41 | 4.1 % | 118.63 | (4.5 %) | 62.06 | (1.4 %) |
Q2 2015 | 255.10 | 4.4 % | 115.78 | (6.7 %) | 63.05 | (0.3 %) |
Q3 2015 | 231.63 | 0.5 % | 98.68 | (12.7 %) | 49.14 | (9.2 %) |
Q4 2015 | 259.94 | 5.2 % | 113.72 | (3.2 %) | 60.66 | 14.8 % |
2015 | 1,000.08 | 10.7 % | 446.81 | 7.1 % | 234.90 | 0.7 % |
Q1 2016 | 303.59 | 19.8 % | 143.50 | 21.0 % | 75.66 | 21.9 % |
Q2 2016 | 300.21 | 17.7 % | 139.76 | 20.7 % | 71.70 | 13.7 % |
Q3 2016 | 280.24 | 21.0 % | 124.29 | 26.0 % | 56.32 | 14.6 % |
Q4 2016 | 359.19 | 38.2 % | 168.91 | 48.5 % | 84.39 | 39.1 % |
2016 | 1,243.22 | 24.3 % | 576.45 | 29.0 % | 288.06 | 22.6 % |
Q1 2017 | 362.97 | 19.6 % | 173.37 | 20.8 % | 93.17 | 23.1 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2007 | 400.67 | 16.8 % | 173.39 | 28.0 % | 96.18 | 54.2 % |
2008 | 454.55 | 13.4 % | 200.90 | 15.9 % | 110.24 | 14.6 % |
2009 | 517.60 | 13.9 % | 228.00 | 13.5 % | 121.20 | 9.9 % |
2010 | 587.49 | 13.5 % | 277.05 | 21.5 % | 142.87 | 17.9 % |
2011 | 678.44 | 15.5 % | 324.00 | 16.9 % | 169.26 | 18.5 % |
2012 | 796.51 | 17.4 % | 372.71 | 15.0 % | 186.04 | 9.9 % |
2013 | 902.24 | 13.3 % | 455.80 | 22.3 % | 222.25 | 19.5 % |
2014 | 903.79 | 0.2 % | 417.17 | (8.5 %) | 233.17 | 4.9 % |
2015 | 1,000.08 | 10.7 % | 446.81 | 7.1 % | 234.90 | 0.7 % |
2016 | 1,243.22 | 24.3 % | 576.45 | 29.0 % | 288.06 | 22.6 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2008 | 25.90 | - | 0.13 | - | 25.90 | 0.13 |
Q2 2008 | 26.63 | - | 0.13 | - | 26.63 | 0.13 |
Q3 2008 | 20.47 | - | 0.10 | - | 20.47 | 0.10 |
Q4 2008 | 24.07 | - | 0.12 | - | 24.07 | 0.12 |
2008 | 97.07 | 9.4 % | 0.49 | - | 97.07 | 0.49 |
Q1 2009 | 26.55 | 2.5 % | 0.13 | - | 26.55 | 0.13 |
Q2 2009 | 34.03 | 27.8 % | 0.17 | - | 34.03 | 0.17 |
Q3 2009 | 21.88 | 6.9 % | 0.11 | - | 21.88 | 0.11 |
Q4 2009 | 24.58 | 2.1 % | 0.12 | - | 24.58 | 0.12 |
2009 | 107.04 | 10.3 % | 0.54 | - | 107.04 | 0.54 |
Q1 2010 | 32.37 | 21.9 % | 0.16 | - | 32.37 | 0.16 |
Q2 2010 | 34.77 | 2.2 % | 0.17 | - | 34.77 | 0.17 |
Q3 2010 | 23.14 | 5.8 % | 0.12 | - | 23.14 | 0.12 |
Q4 2010 | 28.28 | 15.1 % | 0.14 | - | 28.28 | 0.14 |
2010 | 118.57 | 10.8 % | 0.59 | - | 118.57 | 0.59 |
Q1 2011 | 39.14 | 20.9 % | 0.20 | - | 39.14 | 0.20 |
Q2 2011 | 40.49 | 16.4 % | 0.20 | - | 40.49 | 0.20 |
Q3 2011 | 33.71 | 45.7 % | 0.17 | - | 33.71 | 0.17 |
Q4 2011 | 34.72 | 22.8 % | 0.17 | - | 34.72 | 0.17 |
2011 | 148.06 | 24.9 % | 0.74 | - | 148.06 | 0.74 |
Q1 2012 | 46.34 | 18.4 % | 0.23 | - | 46.34 | 0.23 |
Q2 2012 | 47.26 | 16.7 % | 0.24 | - | 47.26 | 0.24 |
Q3 2012 | 35.44 | 5.1 % | 0.18 | - | 35.44 | 0.18 |
Q4 2012 | 42.56 | 22.6 % | 0.21 | - | 42.56 | 0.21 |
2012 | 171.60 | 15.9 % | 0.86 | - | 171.60 | 0.86 |
Q1 2013 | 52.52 | 13.3 % | 0.26 | - | 52.52 | 0.26 |
Q2 2013 | 54.16 | 14.6 % | 0.27 | - | 54.16 | 0.27 |
Q3 2013 | 44.11 | 24.5 % | 0.22 | - | 44.11 | 0.22 |
Q4 2013 | 50.42 | 18.4 % | 0.25 | - | 50.42 | 0.25 |
2013 | 201.20 | 17.3 % | 1.01 | - | 201.20 | 1.01 |
Q1 2014 | 57.94 | 10.3 % | 0.29 | - | 57.94 | 0.29 |
Q2 2014 | 59.44 | 9.8 % | 0.30 | - | 59.44 | 0.30 |
Q3 2014 | 71.99 | 63.2 % | 0.36 | 21.70 | 50.29 | 0.25 |
Q4 2014 | 50.75 | 0.7 % | 0.25 | 2.20 | 48.55 | 0.24 |
2014 | 240.12 | 19.3 % | 1.20 | 23.90 | 216.22 | 1.08 |
Q1 2015 | 55.93 | (3.5 %) | 0.28 | - | 55.93 | 0.28 |
Q2 2015 | 56.09 | (5.6 %) | 0.28 | - | 56.09 | 0.28 |
Q3 2015 | 42.99 | (40.3 %) | 0.21 | - | 42.99 | 0.21 |
Q4 2015 | 53.80 | 6.0 % | 0.27 | - | 53.80 | 0.27 |
2015 | 208.80 | (13.0 %) | 1.04 | - | 208.80 | 1.04 |
Q1 2016 | 68.47 | 22.4 % | 0.34 | - | 68.47 | 0.34 |
Q2 2016 | 63.70 | 13.6 % | 0.32 | - | 63.70 | 0.32 |
Q3 2016 | 49.36 | 14.8 % | 0.25 | - | 49.36 | 0.25 |
Q4 2016 | 75.65 | 40.6 % | 0.38 | - | 75.65 | 0.38 |
2016 | 257.18 | 23.2 % | 1.29 | - | 257.18 | 1.29 |
Q1 2017 | 85.12 | 24.3 % | 0.43 | - | 85.12 | 0.43 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2007 | 88.76 | 40.4 % | 0.44 | - | 88.76 | 0.44 |
2008 | 97.07 | 9.4 % | 0.49 | - | 97.07 | 0.49 |
2009 | 107.04 | 10.3 % | 0.54 | - | 107.04 | 0.54 |
2010 | 118.57 | 10.8 % | 0.59 | - | 118.57 | 0.59 |
2011 | 148.06 | 24.9 % | 0.74 | - | 148.06 | 0.74 |
2012 | 171.60 | 15.9 % | 0.86 | - | 171.60 | 0.86 |
2013 | 201.20 | 17.3 % | 1.01 | - | 201.20 | 1.01 |
2014 | 240.12 | 19.3 % | 1.20 | 23.90 | 216.22 | 1.08 |
2015 | 208.80 | (13.0 %) | 1.04 | - | 208.80 | 1.04 |
2016 | 257.18 | 23.2 % | 1.29 | - | 257.18 | 1.29 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | 44.20 % | 30.76 % | 21.36 % |
2008 | 44.20 % | 30.76 % | 21.36 % |
Q1 2009 | 44.01 % | 30.89 % | 21.00 % |
Q2 2009 | 44.88 % | 32.07 % | 21.57 % |
Q3 2009 | 45.32 % | 32.67 % | 21.40 % |
Q4 2009 | 44.05 % | 30.06 % | 20.68 % |
2009 | 44.05 % | 30.06 % | 20.68 % |
Q1 2010 | 44.67 % | 30.72 % | 21.03 % |
Q2 2010 | 44.66 % | 30.02 % | 20.85 % |
Q3 2010 | 44.76 % | 28.94 % | 20.35 % |
Q4 2010 | 47.16 % | 30.15 % | 20.18 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
Q1 2011 | 48.00 % | 29.97 % | 20.53 % |
Q2 2011 | 47.63 % | 29.54 % | 20.91 % |
Q3 2011 | 47.66 % | 30.31 % | 21.83 % |
Q4 2011 | 47.76 % | 30.40 % | 21.82 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
Q1 2012 | 47.27 % | 30.32 % | 21.95 % |
Q2 2012 | 47.22 % | 30.30 % | 21.81 % |
Q3 2012 | 46.65 % | 28.88 % | 21.18 % |
Q4 2012 | 46.79 % | 28.28 % | 21.54 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
Q1 2013 | 47.40 % | 28.13 % | 21.68 % |
Q2 2013 | 48.62 % | 28.20 % | 21.77 % |
Q3 2013 | 49.59 % | 28.72 % | 22.16 % |
Q4 2013 | 50.52 % | 29.11 % | 22.30 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
Q1 2014 | 50.68 % | 28.86 % | 22.30 % |
Q2 2014 | 50.62 % | 28.77 % | 22.49 % |
Q3 2014 | 50.53 % | 28.82 % | 22.70 % |
Q4 2014 | 49.60 % | 28.54 % | 22.40 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
Q1 2015 | 48.53 % | 28.38 % | 21.96 % |
Q2 2015 | 47.14 % | 28.23 % | 21.38 % |
Q3 2015 | 45.64 % | 28.05 % | 20.62 % |
Q4 2015 | 44.68 % | 28.92 % | 20.88 % |
2015 | 44.68 % | 28.92 % | 20.88 % |
Q1 2016 | 44.91 % | 29.32 % | 21.08 % |
Q2 2016 | 45.25 % | 29.52 % | 20.90 % |
Q3 2016 | 45.57 % | 29.40 % | 20.57 % |
Q4 2016 | 46.37 % | 29.27 % | 20.69 % |
2016 | 46.37 % | 29.27 % | 20.69 % |
Q1 2017 | 46.55 % | 29.66 % | 21.02 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2007 | 43.28 % | 31.24 % | 22.15 % |
2008 | 44.20 % | 30.76 % | 21.36 % |
2009 | 44.05 % | 30.06 % | 20.68 % |
2010 | 47.16 % | 30.15 % | 20.18 % |
2011 | 47.76 % | 30.40 % | 21.82 % |
2012 | 46.79 % | 28.28 % | 21.54 % |
2013 | 50.52 % | 29.11 % | 22.30 % |
2014 | 46.16 % | 30.49 % | 23.92 % |
2015 | 44.68 % | 28.92 % | 20.88 % |
2016 | 46.37 % | 29.27 % | 20.69 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2008 | 46.01 % | 31.17 % | 22.75 % |
Q2 2008 | 45.40 % | 31.49 % | 22.48 % |
Q3 2008 | 45.02 % | 29.90 % | 19.51 % |
Q4 2008 | 40.49 % | 30.38 % | 20.52 % |
Q1 2009 | 45.14 % | 31.63 % | 21.31 % |
Q2 2009 | 48.19 % | 35.49 % | 24.20 % |
Q3 2009 | 46.91 % | 32.66 % | 18.99 % |
Q4 2009 | 36.41 % | 20.87 % | 17.92 % |
Q1 2010 | 47.32 % | 33.89 % | 22.51 % |
Q2 2010 | 47.96 % | 32.68 % | 23.37 % |
Q3 2010 | 46.98 % | 27.76 % | 17.18 % |
Q4 2010 | 46.42 % | 26.45 % | 17.65 % |
Q1 2011 | 50.38 % | 32.72 % | 23.46 % |
Q2 2011 | 46.54 % | 30.78 % | 24.55 % |
Q3 2011 | 47.22 % | 31.20 % | 21.48 % |
Q4 2011 | 46.95 % | 27.37 % | 18.29 % |
Q1 2012 | 48.23 % | 32.08 % | 23.69 % |
Q2 2012 | 46.49 % | 30.64 % | 23.56 % |
Q3 2012 | 44.86 % | 25.18 % | 18.92 % |
Q4 2012 | 47.46 % | 25.28 % | 19.98 % |
Q1 2013 | 50.35 % | 31.12 % | 23.96 % |
Q2 2013 | 51.11 % | 30.61 % | 23.68 % |
Q3 2013 | 49.30 % | 27.68 % | 20.84 % |
Q4 2013 | 51.18 % | 27.14 % | 20.78 % |
Q1 2014 | 50.99 % | 29.94 % | 23.79 % |
Q2 2014 | 50.83 % | 30.16 % | 24.34 % |
Q3 2014 | 49.04 % | 27.98 % | 21.82 % |
Q4 2014 | 47.53 % | 26.09 % | 19.64 % |
Q1 2015 | 46.81 % | 29.28 % | 22.07 % |
Q2 2015 | 45.38 % | 29.50 % | 21.99 % |
Q3 2015 | 42.60 % | 27.19 % | 18.56 % |
Q4 2015 | 43.75 % | 29.55 % | 20.70 % |
Q1 2016 | 47.27 % | 30.60 % | 22.55 % |
Q2 2016 | 46.55 % | 30.20 % | 21.22 % |
Q3 2016 | 44.35 % | 27.12 % | 17.62 % |
Q4 2016 | 47.02 % | 29.03 % | 21.06 % |
Q1 2017 | 47.76 % | 31.79 % | 23.45 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2008 | 200.00 | - | - | 1.90 |
Q2 2008 | 200.00 | - | - | 1.92 |
Q3 2008 | 200.00 | - | - | 2.02 |
Q4 2008 | 200.00 | 0.49 | 0.49 | 2.05 |
Q1 2009 | 200.00 | 0.49 | 0.49 | 2.18 |
Q2 2009 | 200.00 | 0.53 | 0.53 | 2.27 |
Q3 2009 | 200.00 | 0.53 | 0.53 | 2.28 |
Q4 2009 | 200.00 | 0.54 | 0.54 | 2.40 |
Q1 2010 | 200.00 | 0.56 | 0.56 | 2.56 |
Q2 2010 | 200.00 | 0.57 | 0.57 | 2.61 |
Q3 2010 | 200.00 | 0.57 | 0.57 | 2.72 |
Q4 2010 | 200.00 | 0.59 | 0.59 | 2.86 |
Q1 2011 | 200.00 | 0.63 | 0.63 | 3.06 |
Q2 2011 | 200.00 | 0.66 | 0.66 | 3.01 |
Q3 2011 | 200.00 | 0.71 | 0.71 | 3.18 |
Q4 2011 | 200.00 | 0.74 | 0.74 | 3.34 |
Q1 2012 | 200.00 | 0.78 | 0.78 | 3.57 |
Q2 2012 | 200.00 | 0.81 | 0.81 | 3.44 |
Q3 2012 | 200.00 | 0.82 | 0.82 | 3.61 |
Q4 2012 | 200.00 | 0.86 | 0.86 | 3.82 |
Q1 2013 | 200.00 | 0.89 | 0.89 | 4.08 |
Q2 2013 | 200.00 | 0.92 | 0.92 | 3.98 |
Q3 2013 | 200.00 | 0.97 | 0.97 | 4.20 |
Q4 2013 | 200.00 | 1.01 | 1.01 | 4.44 |
Q1 2014 | 200.00 | 1.03 | 1.03 | 4.73 |
Q2 2014 | 200.00 | 1.06 | 1.06 | 4.53 |
Q3 2014 | 200.00 | 1.20 | 1.09 | 4.89 |
Q4 2014 | 200.00 | 1.20 | 1.08 | 5.14 |
Q1 2015 | 200.00 | 1.19 | 1.07 | 5.42 |
Q2 2015 | 200.00 | 1.17 | 1.05 | 5.20 |
Q3 2015 | 200.00 | 1.03 | 1.02 | 5.41 |
Q4 2015 | 200.00 | 1.04 | 1.04 | 5.67 |
Q1 2016 | 200.00 | 1.11 | 1.11 | 5.96 |
Q2 2016 | 200.00 | 1.14 | 1.14 | 5.84 |
Q3 2016 | 200.00 | 1.18 | 1.18 | 6.09 |
Q4 2016 | 200.00 | 1.29 | 1.29 | 6.38 |
Q1 2017 | 200.00 | 1.37 | 1.37 | 6.81 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2007 | 200.00 | 0.44 | 0.44 | 1.77 |
2008 | 200.00 | 0.49 | 0.49 | 2.05 |
2009 | 200.00 | 0.54 | 0.54 | 2.40 |
2010 | 200.00 | 0.59 | 0.59 | 2.86 |
2011 | 200.00 | 0.74 | 0.74 | 3.34 |
2012 | 200.00 | 0.86 | 0.86 | 3.82 |
2013 | 200.00 | 1.01 | 1.01 | 4.44 |
2014 | 200.00 | 1.20 | 1.08 | 5.14 |
2015 | 200.00 | 1.04 | 1.04 | 5.67 |
2016 | 200.00 | 1.29 | 1.29 | 6.38 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2008 | - | - | - |
Q2 2008 | - | - | - |
Q3 2008 | - | - | - |
Q4 2008 | - | - | - |
Q1 2009 | - | - | - |
Q2 2009 | - | - | - |
Q3 2009 | 14.20 | 14.20 | 3.31 |
Q4 2009 | 14.31 | 14.31 | 3.19 |
Q1 2010 | 13.68 | 13.68 | 3.02 |
Q2 2010 | 14.64 | 14.64 | 3.19 |
Q3 2010 | 14.75 | 14.75 | 3.11 |
Q4 2010 | 15.18 | 15.18 | 3.15 |
Q1 2011 | 13.52 | 13.52 | 2.77 |
Q2 2011 | 16.08 | 16.08 | 3.50 |
Q3 2011 | 13.29 | 13.29 | 2.96 |
Q4 2011 | 15.92 | 15.92 | 3.53 |
Q1 2012 | 16.83 | 16.83 | 3.66 |
Q2 2012 | 13.89 | 13.89 | 3.27 |
Q3 2012 | 15.57 | 15.57 | 3.53 |
Q4 2012 | 15.66 | 15.66 | 3.52 |
Q1 2013 | 18.00 | 18.00 | 3.92 |
Q2 2013 | 18.62 | 18.62 | 4.32 |
Q3 2013 | 21.21 | 21.21 | 4.88 |
Q4 2013 | 22.86 | 22.86 | 5.18 |
Q1 2014 | 21.78 | 21.78 | 4.75 |
Q2 2014 | 24.19 | 24.19 | 5.66 |
Q3 2014 | 26.21 | 28.82 | 6.43 |
Q4 2014 | 25.71 | 28.55 | 6.01 |
Q1 2015 | 27.98 | 31.11 | 6.15 |
Q2 2015 | 30.38 | 33.83 | 6.86 |
Q3 2015 | 29.89 | 30.21 | 5.68 |
Q4 2015 | 29.17 | 29.17 | 5.37 |
Q1 2016 | 25.75 | 25.75 | 4.78 |
Q2 2016 | 28.12 | 28.12 | 5.51 |
Q3 2016 | 25.07 | 25.07 | 4.84 |
Q4 2016 | 28.74 | 28.74 | 5.79 |
Q1 2017 | 26.02 | 26.02 | 5.23 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2007 | - | - | - |
2008 | - | - | - |
2009 | 14.31 | 14.31 | 3.19 |
2010 | 15.18 | 15.18 | 3.15 |
2011 | 15.92 | 15.92 | 3.53 |
2012 | 15.66 | 15.66 | 3.52 |
2013 | 22.86 | 22.86 | 5.18 |
2014 | 25.71 | 28.55 | 6.01 |
2015 | 29.17 | 29.17 | 5.37 |
2016 | 28.74 | 28.74 | 5.79 |
Q1 2017
2017
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
Q1 2008 | 86.60 | 26.81 | 0.43 |
Q2 2008 | 91.71 | 26.38 | 0.40 |
Q3 2008 | 84.21 | 20.23 | 0.47 |
Q4 2008 | 84.07 | 31.65 | 1.61 |
Q1 2009 | 94.61 | 29.63 | 0.36 |
Q2 2009 | 105.22 | 28.44 | 6.97 |
Q3 2009 | 92.73 | 26.15 | (3.67) |
Q4 2009 | 103.72 | 33.04 | 0.40 |
Q1 2010 | 109.41 | 32.47 | 1.92 |
Q2 2010 | 114.73 | 34.05 | - |
Q3 2010 | 102.85 | 31.87 | - |
Q4 2010 | 118.91 | 41.29 | - |
Q1 2011 | 129.63 | 37.19 | - |
Q2 2011 | 128.04 | 36.89 | - |
Q3 2011 | 123.09 | 33.84 | - |
Q4 2011 | 149.24 | 40.52 | - |
Q1 2012 | 155.38 | 40.19 | - |
Q2 2012 | 159.24 | 41.38 | - |
Q3 2012 | 149.51 | 37.77 | - |
Q4 2012 | 168.11 | 44.93 | - |
Q1 2013 | 177.18 | 42.05 | - |
Q2 2013 | 186.71 | 42.02 | - |
Q3 2013 | 172.61 | 39.02 | - |
Q4 2013 | 182.05 | 45.21 | - |
Q1 2014 | 196.67 | 46.87 | - |
Q2 2014 | 198.14 | 46.10 | - |
Q3 2014 | 186.70 | 43.78 | - |
Q4 2014 | 137.05 | 48.48 | - |
Q1 2015 | 201.34 | 52.07 | - |
Q2 2015 | 205.21 | 49.89 | - |
Q3 2015 | 189.98 | 41.65 | - |
Q4 2015 | 213.59 | 46.36 | - |
Q1 2016 | 251.45 | 52.14 | - |
Q2 2016 | 250.70 | 49.51 | - |
Q3 2016 | 235.92 | 44.32 | - |
Q4 2016 | 306.32 | 52.87 | - |
Q1 2017 | 310.82 | 52.15 | - |
Period | Medical Services | Pharmaceutical Products | Administration Fees |
---|---|---|---|
2007 | 275.14 | 88.92 | 2.32 |
2008 | 346.58 | 105.06 | 2.91 |
2009 | 396.28 | 117.25 | 4.07 |
2010 | 445.90 | 139.68 | 1.92 |
2011 | 530.00 | 148.44 | - |
2012 | 632.24 | 164.27 | - |
2013 | 718.55 | 168.30 | - |
2014 | 718.55 | 185.23 | - |
2015 | 810.12 | 189.96 | - |
2016 | 1,044.39 | 198.83 | - |
Item | Q1 2017 (e) | Q1 2017 (a) | Change |
---|---|---|---|
Average | 75.80 | 85.12 | 12.29 % |
Item | Q1 2017 (e) | Q1 2017 (a) | Change |
---|---|---|---|
OSOOL AND BAKHEET | 81.80 | 85.12 | 4.1 % |
AlJazira Capital | 76.00 | 85.12 | 12.0 % |
Arbah Capital | 76.00 | 85.12 | 12.0 % |
Sico | 75.00 | 85.12 | 13.5 % |
Albilad Capital | 75.00 | 85.12 | 13.5 % |
Al Rajhi Capital | 71.00 | 85.12 | 19.9 % |
Current | |
Market Cap (M Riyal) | 21,840.00 |
Enterprise Value (EV) (M) | 22,660.65 |
Shares Outstanding ((M)) | 200.00 |
EPS ( Riyal) (TTM) | 3.32 |
Book Value (BV) ( Riyal) | 16.26 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 32.85 |
P/E (TTM) | 32.85 |
Price/book | 6.72 |
Return on Average Assets (%) (TTM) | 13.4 |
Return on Average Equity (%) (TTM) | 21.5 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}